SCHEMBL30848506

SCHEMBL30848506

CC(C)(C)OC(=O)N[C@H]1CC[C@](Cc2cccc(-c3ccccc3)c2)(C(=O)O)C1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KMT2A Q03164 1/20 0.46
▸ L3MBTL1 Q9Y468 1/20 0.46
▸ CTSB P07858 1/20 0.43
▸ CTSS P25774 1/20 0.43
▸ CTSK P43235 1/20 0.43
▸ KDM1A O60341 2/20 0.43
▸ MAOB P27338 1/20 0.43
▸ CKS1B P61024 1/20 0.40
▸ SKP1 P63208 1/20 0.40
▸ SKP2 Q13309 1/20 0.40
▸ USP30 Q70CQ3 1/20 0.39
▸ FAAH O00519 1/20 0.39
▸ BRD4 O60885 1/20 0.39
▸ CREBBP Q92793 1/20 0.39
▸ KCNA3 P22001 1/20 0.39
▸ LIPG Q9Y5X9 1/20 0.38
▸ EPHX2 P34913 1/20 0.38
▸ ACACB O00763 1/20 0.38
▸ CYP1A2 P05177 1/20 0.38
▸ CYP3A4 P08684 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31672663 0.92 KMT2A (0.45) KMT2AL3MBTL1CTSBCTSSCTSK
SCHEMBL4980874 0.91 KMT2A (0.52) KMT2AL3MBTL1KDM1AMAOBCKS1B
SCHEMBL31672630 0.88 KMT2A (0.41) KMT2AL3MBTL1CTSBCTSSCTSK
SCHEMBL31266180 0.80 KMT2A (0.38) KMT2AL3MBTL1CTSKKDM1AMAOB
SCHEMBL30848624 0.79 SSTR1 (0.36) CTSBCTSSCTSKLIPGCYP3A4
SCHEMBL31672605 0.78 KMT2A (0.35) KMT2AL3MBTL1KDM1AMAOBCKS1B
SCHEMBL742036 0.77 KMT2A (0.44) KMT2AL3MBTL1KDM1AMAOBKCNA3
SCHEMBL30848595 0.76 GRIN2B (0.40) FAAH
SCHEMBL31672660 0.76 SSTR1 (0.42) KMT2AL3MBTL1KDM1AMAOBEPHX2
SCHEMBL31500190 0.76 SSTR1 (0.42) KMT2AL3MBTL1KDM1AMAOBEPHX2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260124201-A1 CYCLOPENTANE COMPOUND KISSEI PHARMACEUTICAL CO., LTD. (JP) 2026-05-07 — — US disclosed
EP-4600242-A1 CYCLOPENTANE COMPOUND Kissei Pharmaceutical Co., Ltd. (JP) 2025-08-13 — — EP disclosed
CN-119968355-A Cyclopentane compounds 橘生药品工业株式会社 2025-05-09 — — CN disclosed
WO-2024075825-A1 CYCLOPENTANE COMPOUND キッセイ薬品工業株式会社 2024-04-11 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260124201-A1 CYCLOPENTANE COMPOUND HCRTR1, HCRTR2, CNR1 KMT2A 865/4885L3MBTL1 1954/4885CTSB 2725/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback